Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Classifica tra le azioni #13231
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Prezzo delle azioni
$4.99
Capitalizzazione di mercato
$508.03M
Variazione (1 giorno)
-2.48%
Variazione (1 anno)
2.10%
Paese
TW
Scambia Ever Supreme Bio Technology Co., Ltd (6712)

Categoria

Storico del prezzo dell'azione per Ever Supreme Bio Technology Co., Ltd (6712)
Prezzo di chiusura più alto: $4.88 il 2026-08-01

Prezzo di chiusura più basso: $1.98 il 2018-10-01
Storico del prezzo dell'azione di Ever Supreme Bio Technology Co., Ltd dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.32 38.69%
US
$1.02K 43.79%
NL
$121.01 -13.08%
AU
$139.87 480.61%
US
$749.90 5.87%
CH